As of 2025-07-08, the EV/EBITDA ratio of BioLife Solutions Inc (BLFS) is -214.08. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLFS's latest enterprise value is 983.29 mil USD. BLFS's TTM EBITDA according to its financial statements is -4.59 mil USD. Dividing these 2 quantities gives us the above BLFS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 13.7x | 13.2x |
| Forward P/E multiples | 10.3x - 16.6x | 13.4x |
| Fair Price | (0.10) - 3.34 | 1.39 |
| Upside | -100.5% - -84.7% | -93.6% |
| Date | EV/EBITDA |
| 2025-07-03 | -224.75 |
| 2025-07-02 | -223.82 |
| 2025-07-01 | -212.53 |
| 2025-06-30 | -211.29 |
| 2025-06-27 | -210.77 |
| 2025-06-26 | -210.67 |
| 2025-06-25 | -209.53 |
| 2025-06-24 | -213.98 |
| 2025-06-23 | -209.42 |
| 2025-06-20 | -207.97 |
| 2025-06-18 | -211.08 |
| 2025-06-17 | -213.36 |
| 2025-06-16 | -219.05 |
| 2025-06-13 | -216.36 |
| 2025-06-12 | -229.51 |
| 2025-06-11 | -234.07 |
| 2025-06-10 | -235.83 |
| 2025-06-09 | -235.10 |
| 2025-06-06 | -233.76 |
| 2025-06-05 | -210.87 |
| 2025-06-04 | -216.36 |
| 2025-06-03 | -209.63 |
| 2025-06-02 | -202.49 |
| 2025-05-30 | -214.81 |
| 2025-05-29 | -219.36 |
| 2025-05-28 | -219.68 |
| 2025-05-27 | -218.74 |
| 2025-05-23 | -213.77 |
| 2025-05-22 | -217.09 |
| 2025-05-21 | -216.98 |
| 2025-05-20 | -224.44 |
| 2025-05-19 | -225.78 |
| 2025-05-16 | -232.52 |
| 2025-05-15 | -215.95 |
| 2025-05-14 | -216.57 |
| 2025-05-13 | -227.34 |
| 2025-05-12 | -235.62 |
| 2025-05-09 | -229.41 |
| 2025-05-08 | -219.78 |
| 2025-05-07 | -209.22 |
| 2025-05-06 | -215.53 |
| 2025-05-05 | -238.83 |
| 2025-05-02 | -249.91 |
| 2025-05-01 | -242.97 |
| 2025-04-30 | -237.90 |
| 2025-04-29 | -244.11 |
| 2025-04-28 | -241.63 |
| 2025-04-25 | -246.65 |
| 2025-04-24 | -245.04 |
| 2025-04-23 | -240.39 |